|
1
|
High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence.
|
Clin Cancer Res
|
2004
|
2.75
|
|
2
|
Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition.
|
Cancer Cell
|
2007
|
2.48
|
|
3
|
Global gene expression analysis of reactive stroma in prostate cancer.
|
Clin Cancer Res
|
2009
|
2.34
|
|
4
|
The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.
|
Cancer Res
|
2003
|
2.01
|
|
5
|
Growth and survival mechanisms associated with perineural invasion in prostate cancer.
|
Cancer Res
|
2004
|
1.77
|
|
6
|
Cancer-related axonogenesis and neurogenesis in prostate cancer.
|
Clin Cancer Res
|
2008
|
1.56
|
|
7
|
Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.55
|
|
8
|
Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression.
|
Cancer Res
|
2008
|
1.54
|
|
9
|
Relaxin promotes prostate cancer progression.
|
Clin Cancer Res
|
2007
|
1.34
|
|
10
|
Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy.
|
Hum Pathol
|
2007
|
1.33
|
|
11
|
Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.
|
Cancer Res
|
2011
|
1.32
|
|
12
|
Targeting Aurora kinases for the treatment of prostate cancer.
|
Cancer Res
|
2006
|
1.31
|
|
13
|
Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer.
|
Prostate
|
2005
|
1.24
|
|
14
|
Activation of NF-{kappa}B by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4.
|
Cancer Res
|
2010
|
1.18
|
|
15
|
Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma.
|
Cancer Res
|
2006
|
1.17
|
|
16
|
Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach.
|
Hum Pathol
|
2006
|
1.10
|
|
17
|
FGFR-4 Arg³⁸⁸ enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling.
|
Clin Cancer Res
|
2011
|
1.07
|
|
18
|
GGAP2/PIKE-a directly activates both the Akt and nuclear factor-kappaB pathways and promotes prostate cancer progression.
|
Cancer Res
|
2009
|
1.04
|
|
19
|
Bystin in perineural invasion of prostate cancer.
|
Prostate
|
2006
|
1.01
|
|
20
|
Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens.
|
Am J Pathol
|
2010
|
0.98
|
|
21
|
Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer.
|
Mol Ther
|
2006
|
0.98
|
|
22
|
Reprint of: Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy.
|
Hum Pathol
|
2008
|
0.92
|
|
23
|
Ethnic and racial differences in prostate stromal estrogen receptor alpha.
|
Prostate
|
2005
|
0.88
|
|
24
|
Neuroanatomy of the normal prostate.
|
Prostate
|
2005
|
0.86
|
|
25
|
Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt.
|
Clin Cancer Res
|
2008
|
0.86
|